Express News | Tempest Receives Orphan Drug Designation From the U.S. Food and Drug Administration for Amezalpat to Treat Patients With Hepatocellular Carcinoma (Hcc)

BreakingsJan 6 21:00

Tempest Receives Orphan Drug Designation From the U.S. Food and Drug Administration for Amezalpat to Treat Patients With Hepatocellular Carcinoma (HCC)

Tempest TherapeuticsJan 6 13:00

Express News | Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 7, 2024 05:30

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Tempest TherapeuticsDec 6, 2024 13:00

WeatherFlow-Tempest Secures $3 Million in Growth Capital to Accelerate Innovation in Weather Technology

PR NewswireDec 3, 2024 21:10

Favourable Signals For Tempest Therapeutics: Numerous Insiders Acquired Stock

Yahoo FinanceNov 27, 2024 18:20